Next time you feel an itch, remember that your brain's vast network of neurons informs it whether it is an itch or pain. A ...

The Chronic Pruritus Market is making significant strides, fueled by innovative treatment approaches and ongoing research advancements. DelveInsight’s latest 7MM report delivers deep insights ...

The chronic pruritus therapeutics market has seen a robust growth in recent years. It is forecasted to grow from $10.17 billion in 2024 to $10.94 billion in 2025, demonstrating a compound annual ...

Equities researchers at StockNews.com assumed coverage on shares of Cara Therapeutics (NASDAQ:CARA – Get Free Report) in a ...

Given the late-breaking data on topical ruxolitinib's effectiveness in prurigo nodularis and its rapid itch relief, how do you foresee this impacting treatment paradigms for chronic pruritic ...

StockNews.com began coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Free Report) in a research note issued to investors on Tuesday morning. The brokerage issued a sell rating on the ...

Understanding how these distinct pathways trigger the urge to scratch an itch or move away from pain may help develop more targeted therapies for chronic pain and itchiness. The Difference Is in ...